SIGA 株価分析 — SIGA TECHNOLOGIES INC (Healthcare >> Drug Manufacturers - Specialty & Generic)
SIGA に関するよくある質問
SIGAのPER(株価収益率)は?
SIGA TECHNOLOGIES INC(SIGA)は現在PER 6.57倍で取引されています。
SIGAのROE(自己資本利益率)は?
SIGA TECHNOLOGIES INCのROEは13.36%です。
SIGAの配当利回りは?
SIGA TECHNOLOGIES INCの配当利回りは0.00%です。
SIGAの品質スコア(Quality Score)は?
当社のAIはSIGAの総合財務品質を100点中62点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
SIGAは今が買い時ですか?
当社AIのタイミングスコアは100点中28点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
SIGAはどのセクターに属しますか?
SIGA TECHNOLOGIES INCはHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます(NASDAQ市場)
SIGA AI Analysis Summary
Our AI summary for SIGA: SIGA TECHNOLOGIES INC (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 6.57, ROE of 13.36%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 3.27
Price
0.02
(0.62%)
Day Change
|
|
|---|
SIGA, ファンダメンタルスコアはok ( ファンダメンタル = 62) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is good , ...
| Deepscope 分析 |
|
57% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
211
|
| Magic Formula Rank by ROE |
211
|
| Magic Formula Rank by ROIC |
95
GOOD
|
| Price | 3.27 |
| PBV / Sector |
1.54 / 3.22
GOOD
|
| Earning Per Share | 0.28 |
| PE / Sector |
6.57 / 29.79
GREAT
|
| PEG or PE/Growth / Sector |
0.61 / 0.13
|
| Average 1M Daily Value |
2.67 M
GREAT
|
| Average 1W Daily Value |
4.62 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
72% |
| 配当 |
|
70% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:28 |
| Symbol | SIGA |
| Name | SIGA TECHNOLOGIES INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 71.72 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 233.10 / 10,754.62 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 31 East 62nd Street, New York, NY, United States, 10065
Phone: 212 672 9100
Website: https://www.siga.com
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Google